SAM
TRVI icon

Simplify Asset Management’s Trevi Therapeutics TRVI Stock Holding History

Simplify Asset Management’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-65,412
Closed -$780K – 159
2026
Q1 		$780K Buy
+65,412
New +$732K 0.01% 85
2024
Q3 		– Sell
-200,000
Closed -$596K – 126
2024
Q2 		$596K Hold
200,000
– – 0.04% 82
2024
Q1 		$690K Buy
+200,000
New +$446K 0.04% 79

Other funds holding TRVI

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
PP
PFS Partners Mine Hill, New Jersey $247M AUM 29.02% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Simplify Asset Management's TRVI Position: Q2 2026 in Review

Simplify Asset Management sold out of Trevi Therapeutics (TRVI) in Q2 2026, closing a stake of 65,412 shares — an estimated $780K sold.

Simplify Asset Management first reported a position in TRVI in Q1 2024 and held it in 3 quarters. The position peaked at $780K in Q1 2026. 27 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Simplify Asset Management reported no remaining Trevi Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplify Asset Management sold 65,412 Trevi Therapeutics shares in Q2 2026, an estimated $780K.
  • Simplify Asset Management first reported a position in Trevi Therapeutics in Q1 2024 and held it in 3 quarters.
  • Simplify Asset Management's Trevi Therapeutics position peaked at $780K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.